Docusign
DOCU
$47.71
+4.86%
DocuSign, Inc. is a technology company that provides a cloud-based software suite, the Agreement Cloud, enabling organizations to automate the agreement process and manage legally binding electronic signatures. It is the dominant market leader in the e-signature and agreement automation space, having established itself as the de facto standard for digital transaction management. The current investor narrative revolves around the company's transition from a hyper-growth story to a mature, profitable enterprise, with recent financial results showing margin expansion and positive net income, though this is juxtaposed against concerns over slowing revenue growth and its ability to expand beyond its core e-signature market.…
DOCU
Docusign
$47.71
Investment Opinion: Should I buy DOCU Today?
Rating & Thesis: Hold. DocuSign is a stock in transition, no longer a high-growth story but not yet a compelling value play, trading at a modest 8.7% discount to the average analyst target of $52.15. The core thesis is that the market has correctly de-rated the stock for slowing growth, but the current price fairly balances strong profitability against limited near-term catalysts.
Supporting Evidence: The primary valuation metric, the forward P/E of 9.53x, is low and suggests limited downside if earnings estimates hold. However, this is juxtaposed against single-digit revenue growth of 7.8%, a trailing P/E still at a premium 34.08x, and negative price momentum across all measured periods. The company's strengths are its high gross margin (79.41%), strong free cash flow generation ($1.06B TTM), and minimal debt (D/E of 0.097), which provide a margin of safety.
Risks & Conditions: The two biggest risks are further revenue growth deceleration and a breakdown below the $40.16 technical support level. This Hold rating would upgrade to a Buy if the forward P/E compressed below 8x without a deterioration in earnings estimates, or if the company demonstrated a clear path to re-accelerating revenue growth above 10%. It would downgrade to a Sell if revenue growth fell below 5% or if the stock broke decisively below $40. The stock is currently fairly valued relative to its near-term earnings prospects but remains overvalued on a trailing earnings basis given its growth profile.
Sign up to view all
DOCU 12-Month Price Forecast
DocuSign's investment case hinges on the market accepting its new identity as a mature, cash-generative software company. The deep valuation de-rating (forward P/E of 9.5x) appears to have captured most of the downside from growth slowing, limiting further severe declines. However, with no near-term catalyst for growth re-acceleration and persistent negative technical momentum, a swift recovery is unlikely. The stance would upgrade to Bullish on evidence of sustainable double-digit revenue growth or a significant expansion of the buyback program. It would downgrade to Bearish on a breakdown below $40 or a consecutive quarter of sub-5% revenue growth.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Docusign's 12-month outlook, with a consensus price target around $62.02 and implied upside of +30.0% versus the current price.
Average Target
$62.02
8 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
8
covering this stock
Price Range
$38 - $62
Analyst target range
Analyst coverage for DocuSign is robust, with 8 analysts providing estimates, indicating strong institutional interest. The consensus sentiment leans neutral to cautiously optimistic, as evidenced by recent institutional ratings which include a mix of 'Buy', 'Neutral', and 'Equal Weight' recommendations, with no outright sell ratings in the latest batch. The average target price implied by the estimated EPS of $5.47 and the forward P/E of 9.53x is approximately $52.15, suggesting a modest upside of about 8.7% from the current price of $47.96. The target range, derived from EPS estimates, spans from a low of $4.41 to a high of $6.13, translating to price targets from roughly $42 to $58. The high target assumes successful execution on margin expansion and perhaps a re-acceleration in growth, while the low target likely factors in risks of further growth deceleration or competitive pressures. The relatively tight range between the high and low EPS estimates signals a degree of analyst consensus on the near-term earnings trajectory. The pattern of recent ratings from March 2026 shows all firms reaffirming their existing stances, indicating a period of stability and watchful waiting among analysts following the company's transition phase.
Bulls vs Bears: DOCU Investment Factors
The investment debate for DocuSign is a classic clash between value and growth. The bear case, anchored by severe revenue deceleration to 7.8% and a persistent technical downtrend, currently holds stronger evidence, as reflected in the stock's 40% annual decline. However, the bull case presents a compelling value argument, with the stock trading at a forward P/E of 9.5x alongside robust profitability and a pristine balance sheet. The single most important tension is whether DocuSign's strong free cash flow generation and market leadership can justify its still-elevated trailing P/E of 34x, or if the stock will undergo a permanent de-rating to align with its new identity as a slow-growth, cash-cow enterprise software company.
Bullish
- Strong Profitability & Cash Flow: DocuSign has achieved consistent net income, with a TTM net margin of 9.6% and generated $1.06 billion in TTM free cash flow. This robust profitability and cash generation provide a solid financial foundation for shareholder returns and strategic investments.
- Attractive Forward Valuation: The stock trades at a forward P/E of just 9.53x based on estimated EPS of $5.47, a significant discount to its trailing P/E of 34.08x. This low multiple suggests the market has already priced in a mature, slower-growth phase, creating a potential value opportunity if earnings meet expectations.
- High-Margin, Recurring Revenue Model: The business boasts a robust gross margin of 79.41% and is nearly entirely subscription-based, with 97.9% of Q4 revenue from subscriptions. This model provides predictable, high-quality revenue and significant operating leverage.
- Analyst Consensus Implies Upside: The average analyst target price derived from forward estimates is approximately $52.15, implying an 8.7% upside from the current price of $47.96. With no outright sell ratings in recent coverage, the institutional view is neutral to cautiously optimistic.
Bearish
- Severe Revenue Growth Deceleration: Revenue growth has slowed dramatically to 7.81% YoY in Q4 FY2026, down from hyper-growth levels. This single-digit growth trajectory challenges the company's ability to sustain a premium valuation and raises questions about market saturation.
- Persistent Technical Downtrend: The stock is down 40.68% over the past year and has underperformed the S&P 500 by 69.72 percentage points. Trading near the middle of its 52-week range ($40.16-$94.67), it shows no signs of a durable reversal, reflecting a major loss of investor confidence.
- Elevated Trailing P/E vs. Growth: A trailing P/E of 34.08x is high for a company growing revenue at 7.8%. This valuation premium appears unjustified by the current growth rate and suggests the stock could face further multiple compression if growth does not re-accelerate.
- Lack of Product Diversification: Revenue is overwhelmingly concentrated in the core e-signature subscription business (97.9%). This lack of diversification increases vulnerability to competitive disruption or a slowdown in the core market, limiting the total addressable market expansion narrative.
DOCU Technical Analysis
The stock is entrenched in a severe and sustained downtrend, with a 1-year price change of -40.68% as of the latest data. Currently trading at $47.96, the price sits at approximately 50.7% of its 52-week range ($40.16 to $94.67), indicating it is in the middle of its annual band but has experienced a significant drawdown from its highs, reflecting a major de-rating and loss of investor confidence. The stock has shown a maximum drawdown of -55.51%, underscoring the depth of the sell-off and the substantial risk that has been priced in over the past year. Recent short-term momentum offers little respite, with the stock down 0.44% over the past month and down 8.72% over the past three months, indicating persistent selling pressure. This negative momentum starkly contrasts with the broader market, as evidenced by a relative strength of -10.42 versus the S&P 500 over one month, highlighting significant underperformance. The divergence between the stock's deep negative 1-year trend and its still-negative but less severe 3-month trend could suggest the downtrend is maturing, though it has not yet shown definitive signs of a durable reversal. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $94.67 and critical support at the 52-week low of $40.16. A breakdown below $40.16 would signal a new phase of weakness and likely trigger further selling, while a sustained move above the recent trading range's upper bound near $70 would be needed to suggest a meaningful recovery is underway. With a beta of 0.993, the stock's volatility is nearly identical to the market, but its deep negative performance indicates it has been driven by severe company-specific and sector-related headwinds rather than broad market moves.
Beta
0.88
0.88x market volatility
Max Drawdown
-55.5%
Largest decline past year
52-Week Range
$40-$95
Price range past year
Annual Return
-47.3%
Cumulative gain past year
| Period | DOCU Return | S&P 500 |
|---|---|---|
| 1m | +1.9% | +5.6% |
| 3m | +6.4% | +8.4% |
| 6m | -29.6% | +10.0% |
| 1y | -47.3% | +25.2% |
| ytd | -26.4% | +8.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DOCU Fundamental Analysis
Revenue growth has decelerated into the single digits, with the most recent quarterly revenue (Q4 FY2026) at $836.86 million, representing a year-over-year growth rate of 7.81%. This marks a significant slowdown from the hyper-growth era, as the multi-quarter trend shows revenue sequentially increasing from $763.65M (Q1) to $836.86M (Q4), but the growth rate remains modest. The business is overwhelmingly driven by its subscription segment, which contributed $819.0 million (97.9%) of the total revenue in the latest period, indicating the core product's stability but also a lack of meaningful diversification. The company has achieved consistent profitability, with net income of $90.3 million in the latest quarter and a trailing twelve-month net margin of 9.60%. Gross margins remain robust at 79.41%, reflecting the high-margin, software-as-a-service nature of the business, while the operating margin for the quarter was a healthy 10.48%. The trend shows margins have expanded significantly from periods of losses in prior years, as the company has shifted focus from growth-at-all-costs to operating efficiency and bottom-line results. The balance sheet and cash flow position is strong, with a very low debt-to-equity ratio of 0.097, indicating minimal financial leverage. The company is a prolific generator of free cash flow, with TTM free cash flow of $1.06 billion, providing ample internal funding for growth initiatives and shareholder returns. The return on equity (ROE) of 16.12% is respectable and demonstrates effective use of shareholder capital, while the current ratio of 0.73, though below 1, is mitigated by the strong cash generation and low debt profile.
Quarterly Revenue
$836860000.0B
2026-01
Revenue YoY Growth
+0.07%
YoY Comparison
Gross Margin
+0.79%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DOCU Overvalued?
Given the company's positive net income, the primary valuation metric selected is the Price-to-Earnings (P/E) ratio. The trailing P/E ratio stands at 34.08x, while the forward P/E is significantly lower at 9.53x, based on estimated EPS. This substantial gap implies the market expects a sharp acceleration in earnings growth, likely driven by continued margin expansion and cost discipline, as revenue growth is currently modest. Compared to the broader software industry, a trailing P/E of 34x is elevated, suggesting the market is still assigning a premium for DocuSign's market leadership and profitability, despite its growth deceleration. The premium must be justified by the company's ability to sustain high margins and generate strong free cash flow, which it currently does. Historically, the stock's valuation has compressed dramatically from its peak; the current trailing P/E of 34.08x is well below the historical highs seen in 2021-2022, when P/E ratios were often in the hundreds or even negative. This places the stock near the lower end of its own historical valuation band, which could indicate a value opportunity if the fundamentals stabilize, or it may reflect a permanent de-rating due to the shift to a slower-growth, albeit profitable, business model.
PE
34.1x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -2419x~4651x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
18.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is revenue growth deceleration to 7.8% YoY, which threatens to compress valuation multiples further if it persists. While the company is profitable with a 9.6% net margin, its current ratio of 0.73 indicates potential short-term liquidity constraints, though this is mitigated by strong free cash flow of $1.06 billion. The overwhelming reliance on subscription revenue (97.9%) also creates concentration risk, limiting upside from new business lines and increasing vulnerability to pricing pressure or churn in the core e-signature market.
Market & Competitive Risks: The stock faces significant valuation compression risk, as its trailing P/E of 34.08x is elevated for its growth profile and could decline toward the software sector median. With a beta of 0.99, its volatility aligns with the market, but its severe underperformance (-69.7% relative strength vs. S&P 500) indicates company-specific de-rating. Competitive risks are heightened as the e-signature market matures, with larger platform vendors integrating similar functionality, potentially eroding DocuSign's market leadership and pricing power.
Worst-Case Scenario: The worst-case scenario involves a combination of further growth deceleration below 5%, a failed expansion beyond core e-signatures, and increased competitive pressure leading to margin contraction. This could trigger analyst downgrades and a re-rating to a deep-value multiple, pushing the stock toward its 52-week low of $40.16. From the current price of $47.96, this represents a realistic downside of approximately -16%. A breach of the $40 support could open a path to the mid-$30s, representing a total loss of 25-30% from current levels.
FAQ
The key risks are, in order of severity: 1) Growth Deceleration: Revenue growth has slowed to 7.8% YoY, threatening further multiple compression. 2) Competitive Disruption: The core e-signature market is mature, with larger platform vendors like Adobe and Microsoft offering integrated solutions. 3) Technical Downtrend: The stock is down 40.7% over the past year and shows no confirmed reversal, indicating persistent selling pressure. 4) Valuation Misalignment: The elevated trailing P/E of 34x may not be sustainable if growth remains in single digits, posing a de-rating risk.
The 12-month forecast centers on a base case (60% probability) with a target range of $48 to $55, implying modest upside from the current $47.96. This scenario assumes the company meets analyst EPS estimates of ~$5.47 and revenue growth stabilizes. A bull case (25% probability) targets $58-$65, driven by earnings beats and multiple expansion. A bear case (15% probability) sees the stock retesting its 52-week low near $40. The most likely outcome is range-bound trading, as the market awaits clearer signs of a sustainable business model post-hyper-growth.
DOCU sends mixed valuation signals. It appears significantly undervalued on a forward basis, trading at a P/E of just 9.53x next year's earnings. However, it remains overvalued on a trailing basis with a P/E of 34.08x, given its current 7.8% revenue growth. Compared to its own history, the stock is near the lower end of its valuation band after a 55% drawdown. The market is pricing DOCU as a slow-growth cash cow, implying it is fairly valued to slightly undervalued if it meets forward earnings estimates, but still carries a premium if growth decelerates further.
DOCU is a conditional buy for a specific investor profile. For value investors comfortable with low growth, the forward P/E of 9.5x and strong free cash flow of $1.06 billion present a reasonable margin of safety. However, with revenue growth at just 7.8% and the stock in a persistent downtrend, it is not a good buy for growth-oriented investors or those seeking near-term momentum. The modest 8.7% upside to the average analyst target of $52.15 suggests limited near-term reward, balanced against a potential 16% downside to the 52-week low of $40.16.
DOCU is more suitable for a long-term investment horizon of 2-3 years. As a company in transition from hyper-growth to maturity, it requires time for its earnings and free cash flow to compound and for the market to fully re-rate the stock based on its new financial profile. Its beta of 0.99 indicates market-average volatility, but its company-specific narrative shift creates uncertainty ill-suited for short-term trading. The lack of a dividend also means total return is dependent on price appreciation, which is likely to be gradual. A minimum holding period of 18-24 months is suggested to allow the investment thesis to play out.